There are numerous treatment options available to those with idiopathic pulmonary fibrosis that are effective in easing symptoms. May it be a stubborn, consistent cough or breathlessness, medications idiopathic pulmonary fibrosis can go a long way in improving symptoms.
Even though pulmonary fibrosis is incurable, it can be effectively managed through the use of medications and additional treatment approaches.
There are newer medications that work by impeding the progression of the disease. They can inhibit scarring in the lungs while supplemental treatments can improve shortness of breath, coughing, and fatigue. In addition, they also help to keep infections at bay.
Your treatment plan will be dependent on your particular symptoms, age range, and general health. Work closely with your physician to determine the most effective treatment plan that will ease your symptoms and improve your quality of life.
Medications Idiopathic Pulmonary Fibrosis
There are two medications that work by hindering the formation of scar tissue in the lungs, which is the primary reason patients with PF experience shortness of breath.
These two medications are and pirfenidone; they stop an action in the body that results in the scarring of the lungs. These two drugs also prevent idiopathic pulmonary fibrosis from worsening while making breathing much easier.
Other drugs that work by reducing the inflammation that is associated with scarring in the lungs include:
- Corticosteroids such as
- Immune-system targeting medications such as azathioprine and cyclophosphamide
These medications may be used in conjunction with additional therapies such as rehabilitation and O2 therapy. These options are recommended for improving symptoms such as loss of energy and breathing issues.
Oxygen therapy is highly effective in alleviating shortness of breath to allow patients to be physically active. Rehabilitation, on the other hand, involves strengthening exercises that boost energy and improve breathing.
Featured Image: DepositPhotos/ GladkovPosted on May 23, 2018